Related Experiment Video
Updated: Jun 14, 2025

08:47
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
11.3K
Preclinical toxicity studies supporting 2DG for treatment of status epilepticus
Thomas P Sutula1, Nathan B Fountain2
1Department of Neurology, University of Wisconsin, Madison WI, USA; Hexokine Therapeutics, Inc. Madison WI, USA.
Epilepsy & Behavior : E&B
|September 6, 2024
Abstract:
2-deoxy-D-glucose (2DG) has been proposed as a potential antiseizure treatment based on seizure suppressive actions in multiple acute and chronic seizure models, including models of status epilepticus (SE). Here we summarize recently completed preclinical toxicological studies of single doses of an intravenous formulation of 2DG supporting potential safety of 2DG for acute treatment of SE and acute repetitive seizures (ARS).

